BUCK KRISTEN K (EVP, R&D and CMO) received a stock award from LISATA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/2/2022ACC: 0001879231-22-000006
Officer· EVP, R&D and CMO
Since Sep 2021
-11.96K
Net shares
Net seller
$35.0K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
58K acquired · 69.96K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+58K
Price / share
$0.50
Trade value
$29K
% of position
18.2%
9/1/2022
319.20K→377.20K
Common Stock
Direct
Shares
−25.18K
Price / share
$0.50
Trade value
$12.59K
% of position
6.7%
9/1/2022
377.20K→352.02K
Common Stock
Direct
Shares
−44.78K
Price / share
$0.50
Trade value
$22.39K
% of position
12.7%
9/1/2022
352.02K→307.24K
Total
Net shares
−11.96K
Net value
-$5.98K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/1/2022 | A · Award | +58K | $0.50 | $29K | 18.2% | 319.20K | 377.20K |
| Common Stock Direct | 9/1/2022 | F · Tax Withholding | −25.18K | $0.50 | $12.59K | 6.7% | 377.20K | 352.02K |
| Common Stock Direct | 9/1/2022 | F · Tax Withholding | −44.78K | $0.50 | $22.39K | 12.7% | 352.02K | 307.24K |
| Total | −11.96K | -$5.98K | ||||||
Derivative Transactions0
No derivative transactions reported